Macrophages as a Therapeutic Target in Metastatic Prostate Cancer: A Way to Overcome Immunotherapy Resistance?

SIMPLE SUMMARY: In recent years, therapeutic options for patients with metastatic prostate cancer have improved significantly. However, the efficacy of current immunotherapy strategies in metastatic prostate cancer patients is limited. The prostate cancer tumor microenvironment, which includes immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Martori, Clara, Sanchez-Moral, Lidia, Paul, Tony, Pardo, Juan Carlos, Font, Albert, Ruiz de Porras, Vicenç, Sarrias, Maria-Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773572/
https://www.ncbi.nlm.nih.gov/pubmed/35053602
http://dx.doi.org/10.3390/cancers14020440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773572/
https://www.ncbi.nlm.nih.gov/pubmed/35053602
http://dx.doi.org/10.3390/cancers14020440

Ejemplares similares